SELASU PHARMACIE DU KOCHERSBERG : revenue, balance sheet and financial ratios

SELASU PHARMACIE DU KOCHERSBERG is a French company founded 11 years ago, specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé. Based in WILLGOTTHEIM (67370), this company of category PME shows in 2017 a revenue of 1.0 M€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.

Data updated on 2026-04-25

Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy

Financial history - SELASU PHARMACIE DU KOCHERSBERG (SIREN 808327944)
Indicator 2023 2022 2021 2020 2019 2017 2016 2015
Revenue N/C N/C N/C N/C N/C 1 038 898 € 870 934 € 734 666 €
Net income 88 473 € 49 871 € 51 642 € 77 388 € 90 524 € -118 300 € 30 186 € -56 654 €
EBITDA N/C N/C N/C N/C N/C -7 867 € 70 743 € -9 704 €
Net margin N/C N/C N/C N/C N/C -11.4% 3.5% -7.7%

Revenue and income statement

In 2023, SELASU PHARMACIE DU KOCHERSBERG generates positive net income of 88 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax.

Net income (2023) ?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax

88 473 €

Loading income statement...

Chart evolution

Show :

Assets

Loading data...

Liabilities

Loading data...

Solvency and debt ratios

The debt ratio (= Financial debt / Equity x 100) stands at 223%. Critical situation: debt significantly exceeds equity, severely limiting borrowing capacity and exposing the company to default risk. Financial autonomy (= Equity / Total assets x 100) reaches 20%. The balance between equity and debt is satisfactory.

Debt ratio (2023) ?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low
50-100% : Moderate
> 100% : High

223.429%

Financial autonomy (2023) ?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy
20-30% : Average
< 20% : Low

20.487%

Asset age ratio (2023) ?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Interpretation
< 50% : Recent assets
50-70% : Normal wear
> 70% : Aging assets

35.6%

Solvency indicators evolution
SELASU PHARMACIE DU KOCHERSBERG

Sector positioning

Debt ratio
223.43 2023
2021
2022
2023
Q1: 20.09
Med: 66.92
Q3: 169.24
Average

In 2023, the debt ratio of SELASU PHARMACIE DU KOCHE... (223.43) ranks above the median of the sector. This ratio measures the weight of debt relative to equity. A reduction effort could improve financial strength.

Financial autonomy
20.49% 2023
2021
2022
2023
Q1: 28.72%
Med: 48.51%
Q3: 68.17%
Average

In 2023, the financial autonomy of SELASU PHARMACIE DU KOCHE... (20.5%) ranks below the median of the sector. This ratio represents the share of equity in total financing. An improvement would strengthen the competitive position.

Liquidity ratios

The liquidity ratio (= Current assets / Current liabilities) stands at 114.76. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.

Liquidity ratio (2023) ?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good
1-1.5 : Fair
< 1 : Liquidity risk

114.764

Liquidity indicators evolution
SELASU PHARMACIE DU KOCHERSBERG

Sector positioning

Liquidity ratio
114.76 2023
2021
2022
2023
Q1: 135.23
Med: 189.76
Q3: 270.17
Watch

In 2023, the liquidity ratio of SELASU PHARMACIE DU KOCHE... (114.76) ranks in the bottom 25% of the sector. This ratio measures the ability to cover short-term debt with current assets. A ratio below 1 may signal potential cash flow tensions.

Working capital requirement (WCR) and payment terms

Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments.

Operating WCR (2023) ?
Operating WCR
Definition
Financing requirement generated by the operating cycle (inventory + receivables - trade payables).
Formula
Inventory + Customer receivables - Trade payables
Interpretation
Negative = cash released
Positive = financing needed

0 €

Customer credit (2023) ?
Customer credit (days)
Definition
Average payment term granted to customers.
Formula
(Customer receivables / Revenue incl. VAT) x 360
Interpretation
< 45j : Good
45-60j : Average
> 60j : Long

0 j

Supplier credit (2023) ?
Supplier credit (days)
Definition
Average payment term obtained from suppliers.
Formula
(Trade payables / Purchases incl. VAT) x 360
Interpretation
The longer the term, the better for cash flow

0 j

Inventory turnover (2023) ?
Inventory turnover (days)
Definition
Average storage duration for goods or materials.
Formula
(Inventory / Cost of goods) x 360
Interpretation
The lower the ratio, the faster the turnover

0 j

WCR and payment terms evolution
SELASU PHARMACIE DU KOCHERSBERG

Positioning of SELASU PHARMACIE DU KOCHERSBERG in its sector

Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé

Valuation estimate

Based on 220 transactions of similar company sales in 2023, the value of SELASU PHARMACIE DU KOCHERSBERG is estimated at 1 043 935 € (range 634 866€ - 1 467 538€). This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.

Estimated enterprise value 2023
220 transactions
634k€ 1043k€ 1467k€
1 043 935 € Range: 634 866€ - 1 467 538€
NAF 5 année 2023

Valuation method used

Net Income Multiple
88 473 € × 11.8x = 1 043 935 €
Range: 634 867€ - 1 467 538€

Only this financial indicator is available for this company.

Valuation evolution

How is this estimate calculated?

This estimate is based on the analysis of 220 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.

  • EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
  • Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
  • Net Income Multiple: Relevant for mature companies with stable results.

This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).

Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)

Compare SELASU PHARMACIE DU KOCHERSBERG with other companies in the same sector:

Voir toutes les statistiques du secteur Commerce de détail de produits pharmaceutiques en magasin spécialisé

Frequently asked questions about SELASU PHARMACIE DU KOCHERSBERG

What is the revenue of SELASU PHARMACIE DU KOCHERSBERG ?

The revenue of SELASU PHARMACIE DU KOCHERSBERG in 2017 is 1.0 M€.

Is SELASU PHARMACIE DU KOCHERSBERG profitable?

Yes, SELASU PHARMACIE DU KOCHERSBERG generated a net profit of 88 k€ in 2023.

Where is the headquarters of SELASU PHARMACIE DU KOCHERSBERG ?

The headquarters of SELASU PHARMACIE DU KOCHERSBERG is located in WILLGOTTHEIM (67370), in the department Bas-Rhin.

Where to find the tax return of SELASU PHARMACIE DU KOCHERSBERG ?

The tax return of SELASU PHARMACIE DU KOCHERSBERG is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).

In which sector does SELASU PHARMACIE DU KOCHERSBERG operate?

SELASU PHARMACIE DU KOCHERSBERG operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.